Đời sống

More domestically produced drug Molnupiravir to treat Covid-19 is licensed

Accordingly, the Drug Administration of Vietnam has licensed one drug, Molnupiravir – to treat Covid-19 domestically produced: Molnupiravir Stella 200 mg, content of Molnupiravir 200mg, hard capsule form, shelf life of 6 months, box of 4 blisters x 10 tablets. Registration number is SKU: VD3-174-22 of Stellapharm Joint Venture Company Limited – Branch 1 (Stellapharm JV Co., Ltd. – Branch 1) production and registration.

The licensing for this drug is valid for 3 years from the date of signing the Decision

Thus, up to now, there have been 4 drugs Molnupiravir – treatment of Covid-19 produced in the country licensed for circulation.

One more drug Molnupiravir to treat Covid-19 is licensed domestically - Photo 1.

Molnupiravir is a drug for symptomatic Covid-19 patients (Artwork BYT).

The Drug Administration of Vietnam requires manufacturing establishments and establishments registering drugs to manufacture according to dossiers and documents registered with the Ministry of Health; coordinate with treatment facilities to strictly comply with current regulations on prescription drugs, monitor the safety, effectiveness, and unwanted effects of drugs on Vietnamese people, and synthesize and report according to regulations.

At the same time, the Department also requested the Department of Health of the provinces and cities to notify medical examination and treatment facilities, medical staff, and drug suppliers in the area to inform patients of the benefits and risks. when using drugs, treatments, other drugs that can replace Molnupiravir in the treatment of Covid-19.

In addition, the Department requires units to strengthen monitoring, supervision and detection of cases of adverse drug reactions (if any), send reports to the National Center for Drug Information and follow Adverse drug reaction monitoring (Hanoi) or Regional Center for drug information and adverse drug reaction monitoring (Ho Chi Minh City).HCM) according to regulations.

The Drug Administration of Vietnam requires the National Center for Drug Information and Adverse Drug Reactions Monitoring – Hanoi University of Pharmacy, and the Regional Center for Drug Information and Adverse Drug Reactions Monitoring in Ho Chi Minh City. Ho Chi Minh City – Cho Ray Hospital, Center for Clinical Pharmacology – Hanoi Medical University are responsible for monitoring, updating and reporting to the Department the following information:

The information contained in the molnupiravir-containing product leaflets is approved in reference countries around the world to update the unified leaflets for molnupiravir medicines.

The decision of the Drug Administration also states that in the course of drug circulation, based on monitoring and updating information on the safety and effectiveness of the three drugs above, the Drug Administration of Vietnam can decide to decided to revoke this granted circulation registration under the provisions of Clause 1, Article 58 of the Law on Pharmacy.

Please watch the video on movement and breathing exercises at home for people with Covid-19:

Instructions for movement and breathing exercises at home for people with Covid-19. Source of the Ministry of Health

You are reading the article More domestically produced drug Molnupiravir to treat Covid-19 is licensed
at Blogtuan.info – Source: danviet.vn – Read the original article here

Back to top button